Ulf Neumann
Novartis (Switzerland) · 100 works · 4,660 citations · h-index 39
Top works
- In vivo detection of amyloid-β deposits by near-infrared imaging using an oxazine-derivative probe
- Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
- 2-(Diethylamino)thieno[1,3]oxazin-4-ones as Stable Inhibitors of Human Leukocyte Elastase
- Novel Thieno[2,3-d][1,3]oxazin-4-ones as Inhibitors of Human Leukocyte Elastase
- Ethylidene protected substrate for the assay of human α-amylase
- Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme
- Decreased amyloid-β and increased neuronal hyperactivity by immunotherapy in Alzheimer's models
- Structure-Based Design, Synthesis, and Memapsin 2 (BACE) Inhibitory Activity of Carbocyclic and Heterocyclic Peptidomimetics
- Pyrazoloheteroaryls: Novel p38α MAP kinase inhibiting scaffolds with oral activity
- Dynamics of Aβ Turnover and Deposition in Different β-Amyloid Precursor Protein Transgenic Mouse Models Following γ-Secretase Inhibition
- Inhibition of cathepsin G by 4H-3,1-benzoxazin-4-ones
- Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
- Pharmacological profile of PKF242‐484 and PKF241‐466, novel dual inhibitors of TNF‐α converting enzyme and matrix metalloproteinases, in models of airway inflammation
- ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine 157
- The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease
- Discovery of Cyclic Sulfone Hydroxyethylamines as Potent and Selective β-Site APP-Cleaving Enzyme 1 (BACE1) Inhibitors: Structure-Based Design and in Vivo Reduction of Amyloid β-Peptides
- BACE1 inhibition more effectively suppresses initiation than progression of β-amyloid pathology
- Inhibition of human chymase by 2-amino-3,1-benzoxazin-4-ones
- Doxycycline Reduces Mortality and Injury to the Brain and Cochlea in Experimental Pneumococcal Meningitis
- A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice